Journal Home > Volume 5 , Issue 1
Journal of Neurorestoratology 2017, 5(1): 73-83 https://doi.org/10.2147/JN.S119581
Expert Opinion | Open Access | Issue | Published: 03 April 2017

Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016)

Show Author's Information Yaping Feng1,*,  Tiansheng Sun2,*,  Lin Chen3,  Jiaxin Xie1,  Zhicheng Zhang2,  Hongyun Huang4( ),  Xijing He5( )
Department of Neurosurgery, Kunming General Hospital of People’s Liberation Army (Spinal Cord Injury Treatment Center of People’s Liberation Army), Kunming, Yunnan,
Department of Orthopedics, Beijing Army General Hospital,
Department of Neurosurgery, Yuquan Hospital, Tsinghua University,
Institute of Neurorestoratology, General Hospital of Armed Police Forces, Beijing,
Department of Orthopedics, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaaxi, China

*These authors contributed equally to this work

Keywords:
cell therapy, spinal cord injury, neurorestorative strategies, neurotization, clinical therapeutic guideline, cordotomy
Cite this article:
Feng Y, Sun T, Chen L, et al. Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016). Journal of Neurorestoratology, 2017, 5(1): 73-83. https://doi.org/10.2147/JN.S119581
Download citation
EndNote(RIS)
BibTeX

453

Views

20

Downloads

Citations

11

Crossref

12

WoS

0

Scopus

N/A

CSCD

Abstract Full text About this article

Restoring functions following spinal cord injury (SCI) was the most challenging task in clinical practice in the past. Fortunately, some effective neurorestorative methods have been exploited in acute, subacute, and chronic phase of SCI. There were no clinical neurorestorative therapeutic guidelines available before this document which can be followed by physicians to manage patients with acute, subacute, and chronic SCI. This guideline will be a helpful reference to physicians to implement their neurorestorative strategies that can help to improve the neurological functions in patients with SCI and their quality of life.


menu
Abstract
Full text
Outline
About this article

Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016)

Show Author's information Yaping Feng1,*, Tiansheng Sun2,*, Lin Chen3, Jiaxin Xie1, Zhicheng Zhang2, Hongyun Huang4( ), Xijing He5( )
Department of Neurosurgery, Kunming General Hospital of People’s Liberation Army (Spinal Cord Injury Treatment Center of People’s Liberation Army), Kunming, Yunnan,
Department of Orthopedics, Beijing Army General Hospital,
Department of Neurosurgery, Yuquan Hospital, Tsinghua University,
Institute of Neurorestoratology, General Hospital of Armed Police Forces, Beijing,
Department of Orthopedics, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaaxi, China

*These authors contributed equally to this work

Abstract

Restoring functions following spinal cord injury (SCI) was the most challenging task in clinical practice in the past. Fortunately, some effective neurorestorative methods have been exploited in acute, subacute, and chronic phase of SCI. There were no clinical neurorestorative therapeutic guidelines available before this document which can be followed by physicians to manage patients with acute, subacute, and chronic SCI. This guideline will be a helpful reference to physicians to implement their neurorestorative strategies that can help to improve the neurological functions in patients with SCI and their quality of life.

Keywords: cell therapy, spinal cord injury, neurorestorative strategies, neurotization, clinical therapeutic guideline, cordotomy

References(77)

1.
Jazayeri SB, Beygi S, Shokraneh F, Hagen EM, Rahimi-Movaghar V. Incidence of traumatic spinal cord injury worldwide: a systematic review. Eur Spine J. 2015;24(5):905-918.
DOI Google Scholar
2.
Sun T. Present status and prospect of spinal cord injury in China. Chin J Spine Spinal Cord. 2014;24(12):1057-1059.
Google Scholar
3.
Feng Y, Zhang W, Feng Y, et al. Early comprehensive treatment strategy for acute spinal cord injury. Chin J Neurosurg Dis Res. 2014;13(5):385-388.
Google Scholar
4.
Specialized Committee of Spine and Spinal Cord Injury; Chinese Society of Rehabilitation Medicine. Expert consensus on evaluation and treatment of early lower cervical spine and spinal cord injury. Chin J Spine Spinal Cord. 2015;25(4):378-384.
Google Scholar
5.
Specialized Committee of Spine and Spinal Cord Injury; Chinese Society of Rehabilitation Medicine. Expert consensus on evaluation and treatment of early thoracolumbar spine and spinal cord injury. Chin J Spine Spinal Cord. 2011;21(11):963-968.
Google Scholar
6.
Xu S, Guo S. Basic and Clinical Medicine of Spinal Cord Injury. Beijing: People’s Medical Publishing House; 2012.
7.
Huang H, Sun T, Chen L, et al. Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury. Cell Transplant. 2014;23(Suppl 1):S5-S17.
DOI Google Scholar
8.
Stein DM, Sheth KN. Management of acute spinal cord injury. Continuum (Minneap Minn). 2015;21(1 Spinal Cord Disorders):159-187.
DOI Google Scholar
9.
Ropper AE, Neal MT, Theodore N. Acute management of traumatic cervical spinal cord injury. Pract Neurol. 2015;15(4):266-272.
DOI Google Scholar
10.
Kirshblum SC, Burns SP, Biering-Sorensen F, et al. International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med. 2011;34(6):535-546.
DOI Google Scholar
11.
Huang H, Xi H, Chen L, Zhang F, Liu Y. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant. 2012;21(Suppl 1):S23-S31.
DOI Google Scholar
12.
Zhu H, Feng YP, Young W, et al. Early neurosurgical intervention of spinal cord contusion: an analysis of 30 cases. Chin Med J (Engl). 2008;121(24):2473-2478.
DOI Google Scholar
13.
Yilmaz T, Kaptanoglu E. Current and future medical therapeutic strategies for the functional repair of spinal cord injury. World J Orthop. 2015;6(1):42-55.
DOI Google Scholar
14.
Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322(20):1405-1411.
DOI Google Scholar
15.
Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury randomized controlled trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597-1604.
DOI Google Scholar
16.
Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the Third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg. 1998;89(5):699-706.
DOI Google Scholar
17.
Hurlbert RJ, Hadley MN, Walters BC, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery. 2015;72(Suppl 2):93-105.
DOI Google Scholar
18.
Evaniew N, Noonan VK, Fallah N, et al; RHSCIR Network. Methylprednisolone for the treatment of patients with acute spinal cord injuries: a propensity score-matched cohort study from a Canadian multi-center spinal cord injury registry. J Neurotrauma. 2015;32(21):1674-1683.
DOI Google Scholar
19.
Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev. 2012;1:CD001046.
DOI Google Scholar
20.
Bauchet L, Lonjon N, Perrin FE, Gilbert C, Privat A, Fattal C. Strategies for spinal cord repair after injury: a review of the literature and information. Ann Phys Rehabil Med. 2009;52(4):330-351.
DOI Google Scholar
21.
Chinnock P, Roberts I. Gangliosides for acute spinal cord injury. Cochrane Database Syst Rev. 2005;2(2):85-86.
DOI Google Scholar
22.
Huang H, Raisman G, Sanberg PR, Sharma H, Chen L. Neurorestoratology. New York: Nova Biomedical; 2015.
23.
Hansebout RR, Hansebout CR. Local cooling for traumatic spinal cord injury: outcomes in 20 patients and review of the literature. J Neurosurg Spine. 2014;20(5):550-561.
DOI Google Scholar
24.
Dididze M, Green BA, Dietrich WD, Vanni S, Wang MY, Levi AD. Systemic hypothermia in acute cervical spinal cord injury: a case-controlled study. Spinal Cord. 2013;51(5):395-400.
DOI Google Scholar
25.
Fehlings MG, Rabin D, Sears W, Cadotte DW, Aarabi B. Current practice in the timing of surgical intervention in spinal cord injury. Spine (Phila Pa 1976). 2010;35(21 Suppl):S166-S173.
DOI Google Scholar
26.
Fehlings MG, Vaccaro A, Wilson JR, et al. Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One. 2012;7(2):e32037.
DOI Google Scholar
27.
Wilson JR, Singh A, Craven C, et al. Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord. 2012;50(11):840-843.
DOI Google Scholar
28.
van Middendorp JJ, Hosman AJ, Doi SA. The effects of the timing of spinal surgery after traumatic spinal cord injury: a systematic review and meta-analysis. J Neurotrauma. 2013;30(21):1781-1794.
DOI Google Scholar
29.
Liu JM, Long XH, Zhou Y, Peng HW, Liu ZL, Huang SH. Is urgent decompression superior to delayed surgery for traumatic spinal cord injury? A meta-analysis. World Neurosurg. 2016;87:124-131.
DOI Google Scholar
30.
Yue JK, Upadhyayula PS, Chan AK, et al. A review and update on the current and emerging clinical trials for the acute management of cervical spine and spinal cord injuries - Part III. J Neurosurg Sci. 2016;60(4):529-542.
Google Scholar
31.
Feng Y, Zhu H, Liu Y. Enhancing training of spinal sub specialty in neurosurgery, improving the level of neuro-spine. Chin J Neurosurg Dis Res. 2011;10(3):193-196.
Google Scholar
32.
Tachibana S, Okada K, Ohwada T, et al. [Posterior longitudinal myelotomy as a surgical treatment of acute cervical spinal cord injury]. No Shinkei Geka. 1984;12(2):183-188. Japanese.
Google Scholar
33.
Yousefifard M, Rahimi-Movaghar V, Nasirinezhad F, et al. Neural stem/progenitor cell transplantation for spinal cord injury treatment; a systematic review and meta-analysis. Neuroscience. 2016;322:377-397.
DOI Google Scholar
34.
Lammertse DP, Jones LA, Charlifue SB, et al. Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial. Spinal Cord. 2012;50(9):661-671.
DOI Google Scholar
35.
McDonald JW, Becker D. Spinal cord injury: promising interventions and realistic goals. Am J Phys Med Rehabil. 2003;82(10 Suppl):S38-S49.
DOI Google Scholar
36.
Wong AMK, Leong CP, Su TY, Yu SW, Tsai WC, Chen CP. Clinical trial of acupuncture for patients with spinal cord injuries. Am J Phys Med Rehabil. 2003;82(1):21-27.
DOI Google Scholar
37.
Bohbot A. Olfactory ensheathing glia transplantation combined with LASERPONCTURE(R) in human spinal cord injury: results measured by electromyography monitoring. Cell Transplant. 2010;19(2):179-184.
DOI Google Scholar
38.
Carlsson CA, Sundin T. Reconstruction of efferent pathways to the urinary bladder in a paraplegic child. Rev Surg. 1967;24(1):73-76.
Google Scholar
39.
Carlsson CA, Sundin T. Reconstruction of afferent and efferent nervous pathways to the urinary bladder in two paraplegic patients. Spine (Phila Pa 1976). 1980;5(1):37-41.
DOI Google Scholar
40.
Zhang S, Johnston L, Zhang Z, et al. Restoration of stepping-forward and ambulatory function in patients with paraplegia: rerouting of vascularized intercostal nerves to lumbar nerve roots using selected interfascicular anastomosis. Surg Technol Int. 2003;11:244-248.
Google Scholar
41.
Lin H, Hou CL, Zhong G, Xie Q, Wang S. Reconstruction of reflex pathways to the atonic bladder after conus medullaris injury: preliminary clinical results. Microsurgery. 2008;28(6):429-435.
DOI Google Scholar
42.
Xiao CG, Du MX, Dai C, Li B, Nitti VW, de Groat WC. An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol. 2003;170(4 Pt 1):1237-1241.
DOI Google Scholar
43.
Brunelli G, von Wild K. Unsuspected plasticity of single neurons after connection of the corticospinal tract with peripheral nerves in spinal cord lesions. J Korean Neurosurg Soc. 2009;46(1):1-4.
DOI Google Scholar
44.
von Wild KR, Brunelli GA. Restoration of locomotion in paraplegics with aid of autologous bypass grafts for direct neurotisation of muscles by upper motor neurons--the future: surgery of the spinal cord? Acta Neurochir Suppl. 2003;87:107-112.
DOI Google Scholar
45.
Yang ML, Li JJ, Zhang SC, et al. Functional restoration of the paralyzed diaphragm in high cervical quadriplegia via phrenic nerve neurotization utilizing the functional spinal accessory nerve. J Neurosurg Spine. 2011;15(2):190-194.
DOI Google Scholar
46.
Harkema S, Gerasimenko Y, Hodes J, et al. Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study. Lancet. 2011;377(9781):1938-1947.
DOI Google Scholar
47.
Minassian K, Jilge B, Rattay F, et al. Stepping-like movements in humans with complete spinal cord injury induced by epidural stimulation of the lumbar cord: electromyographic study of compound muscle action potentials. Spinal Cord. 2004;42(7):401-416.
DOI Google Scholar
48.
Young W. Electrical stimulation and motor recovery. Cell Transplant. 2015;24(3):429-446.
DOI Google Scholar
49.
Fregni F, Boggio PS, Lima MC, et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain. 2006;122(1-2):197-209.
DOI Google Scholar
50.
Soler MD, Kumru H, Pelayo R, et al. Effectiveness of transcranial direct current stimulation and visual illusion on neuropathic pain in spinal cord injury. Brain. 2010;133(9):2565-2577.
DOI Google Scholar
51.
Kern H, Carraro U, Adami N, et al. Home-based functional electrical stimulation rescues permanently denervated muscles in paraplegic patients with complete lower motor neuron lesion. Neurorehabil Neural Repair. 2010;24(8):709-721.
DOI Google Scholar
52.
Kern H, Carraro U, Adami N, et al. One year of home-based daily FES in complete lower motor neuron paraplegia: recovery of tetanic contractility drives the structural improvements of denervated muscle. Neurol Res. 2010;32(1):5-12.
DOI Google Scholar
53.
Wood H. Neural repair and rehabilitation: achieving complex control of a neuroprosthetic arm. Nat Rev Neurol. 2013;9(2):62.
DOI Google Scholar
54.
Collinger JL, Wodlinger B, Downey JE, et al. High-performance neuroprosthetic control by an individual with tetraplegia. Lancet. 2013;381(9866):557-564.
DOI Google Scholar
55.
Hochberg LR, Serruya MD, Friehs GM, et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature. 2006;442(7099):164-171.
DOI Google Scholar
56.
Bouton CE, Shaikhouni A, Annetta NV, et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature. 2016;533(7602):247-250.
DOI Google Scholar
57.
Young W, AlZoubi Z, Saberi H, et al. Beijing declaration of International Association of Neurorestoratology (IANR). J Neurorestoratol. 2015;3:121-122.
Google Scholar
58.
Oraee-Yazdani S, Hafizi M, Atashi A, et al. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome. Spinal Cord. 2016;54(2):102-109.
DOI Google Scholar
59.
Li L, Adnan H, Xu B, et al. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. Eur Spine J. 2015;24(5):919-930.
DOI Google Scholar
60.
Mendonça MV, Larocca TF, de Freitas Souza BS, et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. 2014;5(6):126.
DOI Google Scholar
61.
Saberi H, Firouzi M, Habibi Z, et al. Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. J Neurosurg Spine. 2011;15(5):515-525.
DOI Google Scholar
62.
Ra JC, Shin IS, Kim SH, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011;20(8):1297-1308.
DOI Google Scholar
63.
Bhanot Y, Rao S, Ghosh D, Balaraju S, Radhika CR, Satish Kumar KV. Autologous mesenchymal stem cells in chronic spinal cord injury. Br J Neurosurg. 2011;25(4):516-522.
DOI Google Scholar
64.
Iwatsuki K, Tajima F, Ohnishi YI, et al. A pilot clinical study of olfactory mucosa autograft for chronic complete spinal cord injury. Neurol Med Chir (Tokyo). 2016;56(6):285-292.
DOI Google Scholar
65.
Tabakow P, Raisman G, Fortuna W, et al. Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging. Cell Transplant. 2014;23(12):1631-1655.
DOI Google Scholar
66.
Zhu H, Poon W, Liu Y, et al. Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury. Cell Transplant. Epub 2016 Apr 5.
Google Scholar
67.
Oh SK, Choi KH, Yoo JY, Kim DY, Kim SJ, Jeon SR. A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery. 2016;78(3):436-447.
DOI Google Scholar
68.
Wang S, Lu J, Li YA, et al. Autologous olfactory lamina propria transplantation for chronic spinal cord injury: three-year follow-up outcomes from a prospective double-blinded clinical trial. Cell Transplant. 2016;25(1):141-157.
DOI Google Scholar
69.
Scherf H, Rietschel G. Bemerkenswerte Neunachweise des Auftretens der Dasselfliege Oestromyia leporina (Pallas, 1778) in Deutschland [New noteworthy demonstration of the occurrence of the botfly Oestromyia leporina (Pallas, 1778) in Germany]. Z Parasitenkd. 1967;28(3):223-231. German.
DOI Google Scholar
70.
Doeppner TR, Herz J, Gorgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131-1143.
DOI Google Scholar
71.
Fais S, O’Driscoll L, Borras FE, et al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano. 2016;10(4):3886-3899.
DOI Google Scholar
72.
Harness ET, Yozbatiran N, Cramer SC. Effects of intense exercise in chronic spinal cord injury. Spinal Cord. 2008;46(11):733-737.
DOI Google Scholar
73.
Beekhuizen KS, Field-Fote EC. Sensory stimulation augments the effects of massed practice training in persons with tetraplegia. Arch Phys Med Rehabil. 2008;89(4):602-608.
DOI Google Scholar
74.
Moreh E, Meiner Z, Neeb M, Hiller N, Schwartz I. Spinal decompression sickness presenting as partial Brown-Sequard syndrome and treated with robotic-assisted body-weight support treadmill training. J Rehabil Med. 2009;41(1):88-89.
DOI Google Scholar
75.
Ichim TE, Solano F, Lara F, et al. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med. 2010;3:30.
DOI Google Scholar
76.
Rabinovich SS, Seledtsov VI, Poveschenko OV, et al. Transplantation treatment of spinal cord injury patients. Biomed Pharmacother. 2003;57(9):428-433.
DOI Google Scholar
77.
Ditunno JF Jr, Young W, Donovan WH, Creasey G. The international standards booklet for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Paraplegia. 1994;32(2):70-80.
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Published: 03 April 2017
Issue date: December 2017

Copyright

© 2017 The Author(s).

Rights and permissions

© 2017 Feng et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

Return